Barriers to diagnosing tuberculosis and performing contact investigations amongst the uninsured and non-English speaking populations.
Georgia Public Health Association Annual Meeting and Conference
Part of the Diseases Commons
Works in Diseases
2023
Evaluating the Efficacy of a Stakeholder Advisory Board in Pediatric Palliative Care Health Equity Research
Georgia Public Health Association Annual Meeting and Conference
COVID-19 Deaths among People with HIV in Georgia, 2020–2021
Georgia Public Health Association Annual Meeting and Conference
Prioritizing Brain Health: Building Infrastructure and Community Partnerships to Improve Alzheimer's Disease and Related Dementias Care
Georgia Public Health Association Annual Meeting and Conference
Age-Stratified Model to Assess Health Outcomes of COVID-19 Vaccination Strategies, Ghana
Kelly L. Sullivan
2022
HIV viral load suppression before and after COVID-19 in Kinshasa and Haut Katanga, Democratic Republic of the Congo
Stacy W. Smallwood
Bartonella bacilliformis pathogenesis using Galleria Mellonella larvae as an invertebrate infection model
GS4 Georgia Southern Student Scholarship Symposium
2021
Characterizing the permanence and stationary distribution for a family of malaria stochastic models
Divine Wanduku
2020
Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part III)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part I)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: An Adaptive Hybrid Design for Clinical Development in Rare Diseases
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials in Patients with COVID-19 High Risks
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Accurate COVID-19 Testing in Clinical Trials
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part II)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials with Chronic Conditions
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part II)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part III)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Impacts on Minimization Randomization and Mitigations
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part I)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Independent DMC for Blinded Data Monitoring and Analysis
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Integrated Analysis of Efficacy (IAE) with Adaptive Estimands
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Interim Analysis with Adaptive Estimands Based
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part I)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part III)
Karl E. Peace
Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part II)
Karl E. Peace
2019
The Rocky Road to a Hepatitis C Cure in a Rural HIV Clinic
9th Annual Rural HIV Research and Training Conference (2014-2019)
Analyzing the linkage status of co-infected HIV and HCV patients
9th Annual Rural HIV Research and Training Conference (2014-2019)
A Multicomponent, Multi-Trigger Intervention to Enhance Asthma Control in High-Risk African American Children
R. Christopher Rustin
2018
Routine, Opt-Out HIV Testing in a rural emergency department
9th Annual Rural HIV Research and Training Conference (2014-2019)
Stigma In the Appalachian HIV and Transgender Communities
9th Annual Rural HIV Research and Training Conference (2014-2019)
Empowering Family Physicians to Control HIV Infection in Rural Communities
9th Annual Rural HIV Research and Training Conference (2014-2019)
HIV and HCV Prevalence Among Patients Tested at Rural Sites of a Multi-site FQHC
9th Annual Rural HIV Research and Training Conference (2014-2019)
Evaluating Oral Health Services in RWPB Clinics, Georgia DPH, 2015-2016
9th Annual Rural HIV Research and Training Conference (2014-2019)
Social media and implications of online HIV PrEP retrieval
9th Annual Rural HIV Research and Training Conference (2014-2019)
2017
2016
2015
Incidence of Hyponatremia in the Adult, Inpatient Setting: Towards an Improved Falls Risk Assessment Tool
GS4 Georgia Southern Student Scholarship Symposium
2014
Histological Analysis of Osteoclastic Activity in Bisphosphonate-Treated Rats
Georgia Undergraduate Research Conference (2014-2015)
Strategies to Improve Social-Interaction and Mental-Health among Rural HIV/AIDS Populations
9th Annual Rural HIV Research and Training Conference (2014-2019)
2013
HIV/AIDS: Children, Youth, and Families
Department of Leadership, Technology, and Human Development Faculty Presentations